GlassScriptPhysician profile
Emilie Seitz
NPI 1023647617
$8,091.87
in general payments reported to CMS, 2019-2025
20 companies · $3,548 in 2025
The $3,548 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $2,278 · 2023: $865 · 2024: $1,183 · 2025: $3,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,863 · Consulting Fee: $2,625 · Entertainment: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,863.22 |
| Consulting Fee | $2,625.00 |
| Entertainment | $107.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,227.51 | 2022-2025 | Infuse, Xiidra, Miebo |
| Coopervision INC. | $1,595.61 | 2022-2025 | Myday Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $506.92 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $408.84 | 2022-2024 | Acuvue |
| Dompe US, INC. | $362.22 | 2022-2024 | Oxervate |
| Harrow Eye, LLC | $353.47 | 2024-2025 | Vevye |
| Abbvie INC. | $323.55 | 2022-2025 | |
| Oyster Point Pharma, INC. | $310.02 | 2022-2024 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $290.58 | 2023-2025 | Tryptyr, Hydrus Microstent, Total30 |
| Sun Pharmaceutical Industries INC. | $197.82 | 2021-2024 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $129.24 | 2021 | |
| Optos, INC. | $107.36 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Notal Vision, INC. | $70.64 | 2024 | Foresee Home |
| Biotissue Holdings INC. | $64.36 | 2023-2025 | |
| Quidel Corporation | $41.34 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.35 | 2022 | |
| Thea Pharma INC. | $23.92 | 2023 | |
| Ani Pharmaceuticals, INC. | $21.14 | 2023 | Purified Cortrophin Gel |
| Kala Pharmaceuticals, INC. | $13.00 | 2021 | |
| Sight Sciences, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilie Seitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.